Somatic RET gene activating mutations are present also in a variety of cancer, including desmoplastic melanoma (20%), cutaneous squamous cell carcinoma (10%), melanoma (6.6%), colorectal carcinoma (3.6%–6.9%), breast cancer, urothelial carcinoma, or paraganglioma [5,16,48]. This evidence concerns the gene RET and cancer.